The efficacy of Elbasvir/Grazoprevir fixed-dose combination for 8 weeks in HCV treatment and health-related quality of life (HRQoL) in treatment-naïve, non-cirrhotic, genotype 4-infected patients (ELEGANT-4): A single-center, single-arm, open-label, phase 3 trial
| Autor: | AlEid, Ahmad1, Al Balkhi, Areej1, Qutub, Adel1, Abbarh, Shahem1, AlLehibi, Abed1, Almtawa, Abdullah1, Al Otaibi, Nawwaf1, AlGhamdi, Ahmed1, AlGhamdi, Adel1, Alamr, Abdulrahman1, Ahmad, Shameem1, Al Sayari, Khalid1, Al Ibrahim, Bashaar1, AlKhathlan, Abdullah1 |
|---|---|
| Zdroj: | Saudi Journal of Gastroenterology. May/Jun2022, Vol. 28 Issue 3, p225-232. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|